Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience
Maël Heiblig(Université Claude Bernard Lyon 1), Xavier Thomas(Hôpital Lyon Sud), Adriana Pleșa(Hospices Civils de Lyon), Pierre Sujobert(Université Claude Bernard Lyon 1), Fiorenza Barraco(Hôpital Lyon Sud), Étienne Paubelle(Centre Hospitalier Universitaire Amiens-Picardie), Mauricette Michallet(Université Claude Bernard Lyon 1), Franck E. Nicolini(Inserm), Isabelle Tigaud(Inserm), Hélène Labussière‐Wallet(Hospices Civils de Lyon), Gilles Salles(Memorial Sloan Kettering Cancer Center), Eric Wattel(Université Claude Bernard Lyon 1), Sophie Ducastelle(Hôpital Lyon Sud), Sandrine Hayette(Hôpital Claude Huriez), Marie Balsat(Hôpital Claude Huriez)
Cited by 17
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606